Recon,/Homorelaps197822.html,(1080P,Sports Outdoors , Sports Fitness , Hunting Fishing,$111,Advantage,B,laagvlieger.x24hr.com,Video),20MP,Force,Browning,Camera,Trail $111 Browning Recon Force Advantage 20MP Trail Camera (1080P Video) B Sports Outdoors Sports Fitness Hunting Fishing Browning Recon Force Advantage Product 20MP 1080P Camera Video B Trail $111 Browning Recon Force Advantage 20MP Trail Camera (1080P Video) B Sports Outdoors Sports Fitness Hunting Fishing Recon,/Homorelaps197822.html,(1080P,Sports Outdoors , Sports Fitness , Hunting Fishing,$111,Advantage,B,laagvlieger.x24hr.com,Video),20MP,Force,Browning,Camera,Trail Browning Recon Force Advantage Product 20MP 1080P Camera Video B Trail

Browning Recon Force Advantage Product 20MP Selling rankings 1080P Camera Video B Trail

Browning Recon Force Advantage 20MP Trail Camera (1080P Video) B

$111

Browning Recon Force Advantage 20MP Trail Camera (1080P Video) B

|||

Product description

The Recon Force Advantage camera features an adjustable detection range from 55ft. - 80 ft. and 3 adjustable IR flash modes for optimum picture control at night. Another great feature is the built in 2-inch color display to preview images and videos right in the field. The Recon Force Advantage also features the highest quality 20MP pictures and 1920 x 1080 Full HD video quality in either 30 or 60 frames per second for the most incredible video clips of game on your property. Additional features for the 2018 model include Smart IR video, which continues to record video footage while game is moving in front of the camera and SD card management options which allow you to overwrite older images on the SD card if the memory is full. The Recon Force Advantage is also compatible with up to 512 GB SDXC memory cards.

Bundle Includes:

  • Browning Trail Cameras Recon Force Advantage 20MP Game Camera
  • SanDisk Ultra SDHC 16GB 80MB/S Class 10 Flash Memory Card
  • Focus All In One High Speed USB 2.0 Card Reader

Browning Recon Force Advantage 20MP Trail Camera (1080P Video) B

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA